Kura Oncology, Inc. (KURA)
8.65
-0.19
(-2.15%)
USD |
NASDAQ |
Mar 13, 16:00
8.67
+0.02
(+0.23%)
After-Hours: 20:00
Kura Oncology EPS Diluted (Quarterly) : -0.9199 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lexicon Pharmaceuticals, Inc. | -0.0427 |
| Viemed Healthcare, Inc. | 0.1483 |
| Liquidia Corp. | 0.1455 |
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -81.00M |
| Revenue (Quarterly) | 17.34M |
| Total Expenses (Quarterly) | 98.34M |
| Enterprise Value | 117.27M |
| Gross Profit Margin (Quarterly) | 97.35% |
| Profit Margin (Quarterly) | -467.2% |
| Earnings Yield | -36.73% |
| Normalized Earnings Yield | -36.73 |